Article -> Article Details

Cenforce 100 mg is a vasodilating agent; it is a selective phosphodiesterase (PDE) type 5 inhibitor. It is very effective medicine that is widely and genuinely available at Powpills for most reasonable prices.

What are the uses of Cenforce 100 mg?

Erectile Dysfunction (ED)- ED is a condition that is commonly found in many men. It is a stance where man is not able to attain firm erection for complete sexual function. Thus males with issues of impotency or Erectile Dysfunction often resort to the medicine.  

As per experts it is recommended that selective PDE type 5 inhibitors is offered as the first course for the therapy for ED otherwise contraindicated. It should be kept in mind that erection occurs only when there is sexual stimulation ands not because of the medicine. The medicine just helps or works to get erection if the person is sexually stimulated.

Sexual Dysfunction in women-

The medicine works wonders in women and helps them to treat sexual dysfunction. Cenforce 100 mg and Fildena 100Mg works for the betterment of physiologic response that it works to increase blood flow to sexual organs but then again sexual stimulation and desire to indulge in sexual intercourse needs to be there. 

Thus overall sexual dysfunction in women is cured with the medicine. Also for women with sexual dysfunction as a result of SSRI antidepressants and in females with neurogenic sexual dysfunction, which has occurred due to spinal cord injury or multiple sclerosis, are cured with the medicine.

Pulmonary Arterial Hypertension (PAH)

Symptomatic management of PAH (WHO group 1 Pulmonary hypertension) to improve exercise capacity and delays clinical worsening. Parenteral preparation is used for the continuous treatment in patients with PAH who cannot take medicines through mouth. It has been observed in clinical studies that patients with NYHA/WHO functional class II-III PAH (idiopathic or is seen together with connective tissue diseases).

It is one of the highly recommended treatments for the initial management of PAH in patients with NYHA/WHO functional class II, III, and IV symptoms who are not patients for calcium-channel blocker therapy or for patients who are not responding to such therapy that is put on them. It is the choice of the patient who needs to consider like disease severity, route of administration, potential adverse effects and also the cost of treatment, clinician experience and patient preference.

There are patients who do not respond to initial monotherapy and could often respond to combination therapy with the help of prostanoid or endothelin –receptor antagonist (which are introduced subsequently). There are different ways to resume the treatment and target different pathophysiologic pathways of the disease. the additive therapy targeted in combination provides additional benefits

Often in clinical experience it is observed that there are patients who do not present adequate results with the treatment. There are cases or morality it has been observed that in children receiving higher doses of sildenafil. FDA does not recommend the use of the medicine in pregnant ladies and children below the age of 18.